Saturday, October 31, 2026

Facebook Stock Rose On Monday, Outperforms Market

ViaNews Editorial Team

December 28, 2020

Facebook Stock Rose On Monday, Outperforms Market

NASDAQ Composite ended the session with Facebook rising 3.24% to $276.06 on Monday while nASDAQ Composite rose 0.92% to $12,922.18.

Facebook today's close was $276.06, 10.36% under its 52-week high of $304.67.

News about Facebook today

Tips industries, Facebook ink licensing deal. According to today's article on Bloomberg Quint, "had announced a global deal with Facebook Inc. to license its music for video and other social experiences across Facebook and Instagram.", "With the move, Facebook and Instagram users will be able to add Tips' music catalogue to their posts and stories, the statement added."

Facebook's Sales

Facebook's sales growth is 24.7% for the present quarter and 24.7% for the next. The company's growth estimates for the ongoing quarter and the next is 24.6% and 21.1%, respectively.

Facebook's Revenue

Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 78.98B for the twelve trailing months.

Volatility

Facebook's last day, last week, and last month's average volatility was a negative 0.27%, a negative 0.53%, and a negative 0.17%, respectively.

Facebook's last day, last week, and last month's high and low average amplitude percentage was 1.58%, 2.30%, and 2.63%, respectively.

Facebook's Stock Yearly Top and Bottom Value

Facebook's stock is valued at $276.06 at 16:06 EST, under its 52-week high of $304.67 and way higher than its 52-week low of $137.10.

Facebook's Moving Average

Facebook's value is above its 50-day moving average of $276.03 and higher than its 200-day moving average of $262.30.

Previous days news about Facebook

Facebook shutting irish units at center of tax dispute: times. According to Bloomberg Quint on Sat Dec 26, "The move to wind down the units started after the U.S. Internal Revenue Service took Facebook to court, saying the social media company was shifting funds through Ireland to avoid U.S. taxes, the Times said. ", "The Irish companies were used to hold its intellectual property for international sales, and Facebook companies around the world would pay the units for the use of the IP, shifting much of the sales outside the U.S., the newspaper said. "

16 leaders from firms like Facebook, darktrace, revolut reflect on how the pandemic upended the way they work and live, and what 2021 will look like. According to Business Insider on Sun Dec 27, "We spoke to 15 CEOs, founders, and executives from firms such as Facebook, Revolut, and Darktrace about how 2020 had changed their priorities in work and life, and the lessons they want to take into 2020."

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com